Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.42 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL28360045 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TAAR1ESR2SLC6A2SLC6A4 | |
| SCHEMBL21578555 | 0.97 | ALDH1A1 (0.50) | ALDH1A1TAAR1ESR2SLC6A2SLC6A4 | |
| SCHEMBL16887401 | 0.97 | ALDH1A1 (0.50) | ALDH1A1TAAR1ESR2SLC6A2SLC6A4 | |
| SCHEMBL13699010 | 0.94 | ALDH1A1 (0.53) | ALDH1A1TAAR1ESR2SLC6A2SLC6A4 | |
| SCHEMBL18818912 | 0.89 | TAAR1 (0.52) | ALDH1A1TAAR1ESR2MAOACYP3A4 | |
| Acetic Acid SCHEMBL20507030 | 0.86 | MAPT (0.48) | ESR2CNR1CNR2AKR1C2AKR1C1 | |
| SCHEMBL12562821 | 0.84 | SLC6A4 (0.45) | TAAR1ESR2SLC6A4SLC6A3NOTUM | |
| SCHEMBL23733868 | 0.84 | MEN1 (0.50) | ALDH1A1TAAR1TDP1CTDSP1MAPK1 | |
| SCHEMBL4547010 | 0.84 | CYP19A1 (0.53) | ALDH1A1TDP1CTDSP1 | |
| SCHEMBL18674206 | 0.84 | ALOX5AP (0.42) | ALDH1A1TAAR1ESR2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-218077904-U | Batching kettle equipment for preparing propylpyran-3,5-difluorobiphenyl | 石家庄市凯信电子材料有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-112290087-A | Wide-temperature lithium ion battery electrolyte and lithium ion battery containing electrolyte | 杉杉新材料（衢州）有限公司 | 2021-01-29 | — | — | CN | claimed |
| CN-112234252-A | Wide-temperature-range lithium ion battery non-aqueous electrolyte for high voltage and lithium ion battery | 杉杉新材料（衢州）有限公司 | 2021-01-15 | — | — | CN | claimed |
| CN-111029656-A | Lithium ion battery non-aqueous electrolyte and lithium ion battery thereof | 杉杉新材料（衢州）有限公司 | 2020-04-17 | — | — | CN | claimed |
| EP-1667958-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-14 | — | — | EP | claimed |
| WO-2005033063-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-14 | — | — | WO | claimed |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-07 | — | — | US | claimed |
| US-20250359482-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-11-20 | — | — | US | disclosed |
| CN-116948656-B | Application of ionic liquid in preparation of fluoroalkyl cyclohexyl biphenyl liquid crystal compounds | 河北美星化工有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118255647-A | Preparation method of compound containing fluorine substituted cyclohexylphenyl group | 晶美晟光电材料（南京）有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-116948656-A | Application of ionic liquid in preparation of fluoroalkyl cyclohexyl biphenyl liquid crystal compounds | 河北美星化工有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
| EP-4208465-A1 | MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS | Orexia Therapeutics Limited (GB) | 2023-07-12 | — | — | EP | disclosed |
| EP-0108978-B1 | PROCESS FOR PREPARING POLY(ARYLENE SULFIDES) WHICH CAN BE BRANCHED | BAYER AG (DE) | 1986-09-03 | — | — | EP | disclosed |
| US-4501884-A | Process for the production of optionally branched polyarylene sulphide with piperazinone solvent | BAYER AKTIENGESELLSCHAFT (DE) | 1985-02-26 | — | — | US | disclosed |
| US-4500702-A | Anhydrous preparation of polyarylene sulfide in one vessel reaction system | BAYER AKTIENGESELLSCHAFT (DE) | 1985-02-19 | — | — | US | disclosed |
| US-4464507-A | Process for the production of high molecular weight, optionally branched, polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1984-08-07 | — | — | US | disclosed |
| EP-0109637-A2 | Process for preparing highly molecular poly(arylene sulfides) which can be branched | BAYER AG (DE) | 1984-05-30 | — | — | EP | disclosed |
| EP-0108978-A2 | Process for preparing poly(arylene sulfides) which can be branched | BAYER AG (DE) | 1984-05-23 | — | — | EP | disclosed |
| EP-0092723-A2 | Process for preparing high molecular weight polyarylene sulphides which may be branched | BAYER AG (DE) | 1983-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | HPD, TALDO1, OGG1 | ALDH1A1 1554/4885TAAR1 3413/4885ESR2 3792/4885 |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | MCHR1, MCHR2, MC1R | ALDH1A1 3383/4885TAAR1 77/4885ESR2 1314/4885 |
| US-20250359482-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND | CRY1, CCNE2, ELP1 | ALDH1A1 426/4885TAAR1 3507/4885ESR2 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.